SLNCFSilence Therapeutics, Plc.
Price Chart
Loading chart...
About Silence Therapeutics, Plc. (SLNCF)
Silence Therapeutics, Plc. (SLNCF) is a Biotechnology company headquartered in London, United Kingdom whose shares trade over-the-counter on the Pink tier.
SLNCF key facts
- Ticker symbol
- SLNCF
- Market tier
- Pink
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- London, United Kingdom
- Country of incorporation
- GB
- Reporting standard
- U.S. Reporting: SEC Reporting
- Audit status
- Audited
- Fiscal year end
- 12/31
Silence Therapeutics, Plc. leadership
- Phil Haworth — CEO
- Ahmad Ali Mortazavi — CEO
- Max Herrmann — CFO
- Stephanie Diaz — IR
Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with S
Press Releases
Loading press releases...
Latest News
Loading news...
Key Statistics
Major Holders
Loading...
Loading modules...
AI-Powered Stock Analysis
Get a concise 600-word investment analysis for Silence Therapeutics, Plc. (SLNCF) prioritizing the most recent news and developments. Our AI focuses on today's breaking news first, then recent company developments, business updates, strategic initiatives, and current market positioning. Get the most relevant and current analysis available.
Still in beta - Please send feedback after generating your analysis to help us improve!
Smart investment analysis prioritizing breaking news, then recent company developments and strategic insights - completely free!
More Biotechnology Companies on OTC Markets
Investor Reviews
Investor Reviews (0)
Loading reviews...
Company Profile
Loading company profile data...
Contact Information
Company Leadership
Chief Executive Officer
Company Officers
Social Media
Business Details
Stock Details
Loading modules...